Transurethral resection of the bladder tumor (TURBT) followed by intravesical Bacillus Calmette-Guérin (BCG) immunotherapy is a standard treatment for high-risk non muscle-invasive bladder cancer ...

David Morris and Brian Chapin discuss practical management of metastatic hormone-sensitive prostate cancer. The conversation addresses key clinical dilemmas facing urologists and medical oncologists, ...

The immune checkpoint inhibitor combination regimen has become the initial standard of care for metastatic RCC, given its ...

Detalimogene voraplasmid is a novel, investigational, non-integrating, non-viral genetic medicine-based immunotherapy carrying a plasmid that simultaneously expresses IL-12 and regulators of RIG-I.

The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Yair Lotan ...

(UroToday.com) The 2025 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation from Dr. Janet Kukreja discussing a pilot study of a web-based urinary diversion ...

This was a descriptive, observational, and retrospective study of patients who underwent radical prostatectomy and PSMA PET/CT for staging between October 2019 and May 2024. The objective of the study ...

Written by: Tom No BA, Department of Urology, University of California Irvine, during the World Congress of Endourology and Uro-Technology (WCET) Annual Meeting, September 8 – September 12, 2025, ...

Read the Full Video Transcript Daniel Joyce: Hi, my name's Dan Joyce. I'm a urologic oncologist at Vanderbilt University Medical Center. I am extremely excited and honored to be joined by David ...

Posadas EM. Current Advances in Liquid Biopsies for Prostate Cancer. Presented at 2025 World Congress of Endourology and Uro-Technology: September 8 – 12, 2025. Phoenix, Arizona.

Andrea Miyahira hosts Jindan Yu about her team's research on neuroendocrine prostate cancer transformation, published in Nature Genetics. Dr. Yu explains how FOXA2 acts as a pioneer factor driving the ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Sharon Choi discussing comprehensive genomic profiling of Black and non-Hispanic White men with ...